MEDICAL-IS
ActiveSummary
MEDICAL-IS has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €35,474 and a net result of €8,936. The computed 12-month bankruptcy probability is 1.3% (low).
Overview
Official details
Source: KBO- Status
- Active since 25-03-2024 Normal situation
- Activity
- No activity registered in the KBO
- Establishment unit
- 2.357.438.807 1831 Machelen (Brab.), since 25-03-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 24-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.3%
- Gross margin
- €17,439
- ▼ 48.7%
- Turnover
- ≈ €130,000
- estimated
- Profit
- €8,936
- ▼ 73.4%
- Equity
- €35,474
- ▼ 1.7%
- Total assets
- €52,165
- ▲ 43.5%
- 2025 accounts filed 31 days after the deadline
Score breakdownraises riskNo main activity registeredLast filed accounts filed 31 days late; 2 of the last 3 accounts lateFounded in 2024lowers riskLiquidity: current ratio 3.07, cash €31,653Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 57% of them on solvency, 78% on liquidity, 73% on profitability and 39% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 2 accounts on average 51 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Recent changes
- · Gazette deed IncorporationStarting capital €2,500 · Appointments: SANHAYI Ahmed (director) and SANHAYI Imane (director)
Key facts about MEDICAL-IS
- What is the company number of MEDICAL-IS?
- The company number of MEDICAL-IS is 1007.544.047. The VAT number is the same number with BE in front: BE 1007.544.047.
- Where is MEDICAL-IS based?
- The registered office is at Regimentsberg 29, 1831 Machelen (Brab.).Company details
- What is the legal form of MEDICAL-IS?
- The legal form of MEDICAL-IS is Private limited company (BV).
- When was MEDICAL-IS founded?
- MEDICAL-IS was founded on 25-03-2024.
- Is MEDICAL-IS still active?
- Yes, MEDICAL-IS is an active enterprise in the KBO register.
- What is the turnover of MEDICAL-IS?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €17,439 and 6,330 comparable companies of the same size. It probably lies between €61,000 and €320,000. It is a rough estimate.Financials
- Is MEDICAL-IS profitable?
- In financial year 2025, MEDICAL-IS made a profit of €8,936.
- Where can I find the annual accounts of MEDICAL-IS?
- MEDICAL-IS filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MEDICAL-IS due?
- MEDICAL-IS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.